Study of S-1, S-1/CDDP, and 5-FU/CDDP for Advanced Gastric Cancer

NCT00202969 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

180

Enrollment

INDUSTRY

Sponsor class

Conditions

Gastric Cancer

Interventions

DRUG: S-1
DRUG: S-1 plus CDDP
DRUG: 5-FU plus CDDP

Sponsor

Taiho Pharmaceutical Co., Ltd.